PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+6.01%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.87B
AUM Growth
+$434M
(+18%)
Cap. Flow
+$252M
Cap. Flow
% of AUM
8.78%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
100
New
19
Increased
27
Reduced
20
Closed
13
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$103M |
| 2 |
Myriad Genetics
MYGN
|
$82.8M |
| 3 |
Baxter International
BAX
|
$38.7M |
| 4 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$33.5M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$33.2M |
Top Sells
| 1 |
Elevance Health
ELV
|
$52.7M |
| 2 |
iRhythm Technologies
IRTC
|
$40.6M |
| 3 |
Penumbra
PEN
|
$33.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$28M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$27.6M |
Sector Composition
| 1 | Healthcare | 93.52% |
| 2 | Financials | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
26
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $37M | 1.13% |
2,067,684
-159,927
| -7% | -$2.86M |
|
27
Novavax
NVAX
$1.23B
| $36.4M | 1.11% |
200,745
-15,163
| -7% | -$2.75M |
|
28
Cytokinetics
CYTK
$5.89B
| $35.7M | 1.09% |
1,536,373
+565,222
| +58% | +$13.1M |
|
29
Centene
CNC
$14B
| $34.1M | 1.04% |
533,667
+205,188
| +62% | +$13.1M |
|
30
Heron Therapeutics
HRTX
$195M
| $34M | 1.04% |
2,098,578
+87,101
| +4% | +$1.41M |
|
31
Acadia Pharmaceuticals
ACAD
$4.3B
| $33.6M | 1.03% |
1,302,129
+42,655
| +3% | +$1.1M |
|
|
JNCE
32
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $33.5M | 1.02% |
+3,262,833
| New | +$33.5M |
|
|
CANO
33
DELISTED
Cano Health, Inc.
CANO
| $33.5M | 1.02% |
25,266
+8,570
| +51% | +$11.4M |
|
|
34
Syndax Pharmaceuticals
SNDX
$1.37B
| $33.2M | 1.01% |
+1,484,227
| New | +$33.2M |
|
35
Waters Corp
WAT
$17.8B
| $32.1M | 0.98% |
113,089
+18,592
| +20% | +$5.28M |
|
36
Guardant Health
GH
$7.45B
| $31.2M | 0.95% |
204,344
-23,532
| -10% | -$3.59M |
|
37
Insulet
PODD
$24.6B
| $30.9M | 0.94% |
+118,382
| New | +$30.9M |
|
38
Butterfly Network
BFLY
$378M
| $30.8M | 0.94% |
+1,828,311
| New | +$30.8M |
|
39
Dynavax Technologies
DVAX
$1.18B
| $29.4M | 0.9% |
2,990,770
+53,780
| +2% | +$529K |
|
40
Tenet Healthcare
THC
$16.9B
| $29.3M | 0.89% |
563,444
-422,575
| -43% | -$22M |
|
41
Biogen
BIIB
$20.1B
| $28.5M | 0.87% |
102,034
-12,570
| -11% | -$3.52M |
|
42
Intellia Therapeutics
NTLA
$1.23B
| $22.8M | 0.7% |
+284,101
| New | +$22.8M |
|
|
KRTX
43
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $21.5M | 0.66% |
+178,846
| New | +$21.5M |
|
44
Allogene Therapeutics
ALLO
$237M
| $20.8M | 0.64% |
+590,378
| New | +$20.8M |
|
45
DexCom
DXCM
$31.8B
| $20.3M | 0.62% |
+225,768
| New | +$20.3M |
|
|
46
Penumbra
PEN
$10.8B
| $20.1M | 0.61% |
74,351
-125,343
| -63% | -$33.9M |
|
47
Molina Healthcare
MOH
$9.19B
| $16.4M | 0.5% |
70,088
-31,819
| -31% | -$7.44M |
|
|
ADAP
48
Adaptimmune Therapeutics
ADAP
$13.2M
| $13.3M | 0.41% |
2,501,303
-193,466
| -7% | -$1.03M |
|
49
Zai Lab
ZLAB
$3.35B
| $13.3M | 0.4% |
99,375
-7,686
| -7% | -$1.03M |
|
50
Icon
ICLR
$13.8B
| $12.9M | 0.4% |
65,863
-55,460
| -46% | -$10.9M |
|